Search This Blog

Monday, August 20, 2018

Audentes Therapeutics initiated at Citi


Audentes Therapeutics initiated with a Buy at Citi. Citi initiated Audentes Therapeutics with a Buy and $40 price target.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.